Serial precision of metabolite peak area ratios and water referenced metabolite peak areas in proton MR spectroscopy of the human brain

Magnetic Resonance Imaging

Volumn 16, Issue 3, 1998, Pages 319-330

  Simmons, Andrew ^a,b   Smail, Mary ^a   Moore, Elizabeth ^a   Williams, Steven C R ^a,b  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b SOUTH LONDON AND MAUDSLEY NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

In vivo; Magnetic resonance spectroscopy; MRS; Precision; Quantitation

Indexed keywords

ACCURACY; ARTICLE; BRAIN; BRAIN METABOLISM; DATA ANALYSIS; FEMALE; GRAY MATTER; HUMAN; MALE; NORMAL HUMAN; OCCIPITAL LOBE; PHANTOM; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; WHITE MATTER;

ADULT; ASPARTIC ACID; BODY WATER; BRAIN; CHOLINE; CREATINE; ENERGY METABOLISM; EQUIPMENT DESIGN; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE SPECTROSCOPY; MALE; PHANTOMS, IMAGING; PHOSPHOCREATINE; REFERENCE VALUES; SENSITIVITY AND SPECIFICITY; SOFTWARE;

ILEX COOKII;

EID: 0032051580     PISSN: 0730725X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0730-725X(97)00280-4     Document Type: Article

References (51)

1. Connelly A., Jackson G.D., Duncan J.S., King M.D., Gadian D.G. Magnetic resonance spectroscopy in temporal lobe epilepsy. Neurology. 44:1994;1411-1417.
2. Cendes F., Andermann F., Dubeau F., Arnold D.L. Proton magnetic resonance spectroscopic images and MRI volumetric studies for lateralisation of temporal lobe epilepsy. Magn. Reson. Imaging. 13:1995;1187-1191.
3. Ng T.C., Comair Y.G., Xue M., So N., Majors A., Kolem H., Luders H., Modic M. Temporal lobe epilepsy Presurgical localisation with proton chemical shift imaging . Radiology. 193:1994;465-472.
4. Gadian D.G. N-acetylaspartate and epilepsy. Magn. Reson. Imaging. 13:1995;1193-1195.
5. Miller D.H., Austin S.J., Connelly A., Youl B.D., Gadian D.G., McDonald W.I. Proton magnetic resonance spectroscopy of an acute and chronic lesion in multiple sclerosis. Lancet. 337:1991;58-59.
6. Larsson H.B.W., Christiansen P., Jensen M., Frederiksen J., Heltberg A., Olesen J., Henriksen O. Localised in vivo proton spectroscopy in the brain of patients with multiple sclerosis. Magn. Reson. Med. 22:1991;23-31.
7. Arnold D.L., Matthews P.M., Francis G., Antel J. Proton magnetic resonance spectroscopy of human brain in vivo in the evaluation of multiple sclerosis. Assessment of the load of disease. Magn. Reson. Med. 14:1990;154-159.
8. Frahm J., Bruhn H., Hanicke W., Merboldt K.-D., Mursch K., Markaris E. Localised proton NMR spectroscopy of brain tumours using short-echo time STEAM sequences. J. Comput. Assist. Tomogr. 15:1991;915-922.
9. Bruhn H., Michaelis T., Merboldt K.R., et al. On the interpretation of proton NMR spectra from brain tumours in vivo and in vitro. NMR Biomed. 5:1992;253-258.
10. Bruhn H., Frahm J., Gyngell M.L., et al. Noninvasive differentiation of tumours with use of localised H-1 MR spectroscopy in vivo. Initial experience in patients with cerebral tumours. Radiology. 172:1989;541.
11. Kugel H., Heindel W., Ernestus R.I., Bunke J., DuMesnil R., Friedmann G. Human brain tumours. Spectral patterns detected with localised H-1 MR spectroscopy. Radiology. 183:1992;701-709.
12. Meyerhoff D.J., MacKay S., Constans J.M., Norman D., Van Dyke C., Fein G., Weiner M.W. Axonal injury and membrane alterations in Alzheimer's disease suggested by in vivo proton magnetic resonance spectroscopic imaging. Ann. Neurol. 36:1994;40-47.
13. 1H magnetic resonance spectroscopic imaging . Neurology. 43:1993;509-515.
14. Shiino A., Matsuda M., Morikawa S., Inubushi T., Akiguchi O., Handa J. Proton magnetic resonance spectroscopy with dementia. Surg. Neurol. 39:1993;143-147.
15. Moats R.A., Ernst T., Shonk T.K., Ross B.D. Abnormal cerebral metabolite concentrations in patients with probable Alzheimer's disease. Magn. Reson. Med. 32:1994;110-115.
16. Matthews V.P., Barker P.B., Blackband S.J., Chatham J.C., Bryan R.N. Metabolites in patients with acute and subacute strokes Concentrations determined by quantitative proton MR spectroscopy . AJR. 165:1995;633-638.
17. Graham G.D., Blamire A.M., Howseman A.M., Rothman D.L., Fayad P.B., Brass L.M., Petroff O.A.C., Schulman R.G., Prichard J.W. Proton magnetic resonance spectroscopy of cerebral lactate and other metabolites in stroke patients. Stroke. 23:1992;333-340.
18. Saunders D.E., Howe F.A., van den Boogart A., McLean M.A., Griffiths J.R., Brown M.M. Continuing ischemic damage after acute middle cerebral artery infarction in humans demonstrated by short-echo proton spectroscopy. Stroke. 26:1995;1007-1013.
19. Fenstermacher M.J., Narayana P.A. Serial proton magnetic resonance spectroscopy of ischemic brain injury in humans. Invest. Radiol. 25:1990;1034-1039.
20. Grodd W., Krageloh M.I., Peterson D., Trefz F.K., Harzer K. In vivo assessment of N-acetylaspartate in brain in spongy degeneration (Canavan's disease) by proton spectroscopy. Lancet. 23:1990;437-438.
21. 1H NMR spectroscopy in Canavan's disease A report of two cases . Magn. Reson. Med. 19:1991;439-445.
22. Kreis R., Ross B.D., Farrow N.A., Ackermann Z. Metabolic disorders of the brain in chronic hepatic encephalopathy detected with H-1 MR spectroscopy. Radiology. 182:1992;19-27.
23. Kreis R., Farrow N., Ross B.D. Diagnosis of hepatic encephalopathy by proton magnetic resonance spectroscopy. Lancet. 336:1990;635-636.
24. 1H MRS of brain. Magn. Reson. Imaging. 14:1996;281-292.
25. Rose W. Letter to the editor. Magn. Reson. Imaging. 15:1997;381-382.
26. Marshall I., Wardlaw J., Slattery J., Sellar R.J., Cannon J. Letter to the editor. Magn. Reson. Imaging. 15:1997;382-383.
27. Barker P.B., Bryan R.N., Kumar A.J., Naidu S. Proton NMR spectroscopy of Canavan's disease. Neuropediatrics. 23:1992;263-267.
28. 1. A scheme for analysis of in vivo metabolites. J. Magn. Res. 55:1983;357-371.
29. Frahm J., Bruhn H., Gyngell M.L., Merboldt K.D., Hanicke W., Sauter R. Localised proton NMR spectroscopy in different regions of the human brain in vivo. Relaxation times and concentrations of cerebral metabolites. Magn. Reson. Med. 11:1989;47-63.
30. 1H-MRS using water as an internal standard. Magn. Reson. Imaging. 11:1993;107-118.
31. Christiansen P., Toft P., Larsson H.B.W., Stubgaard M., Henriksen O. The concentration of N-acetyl asparate, creatine + phosphocreatine and choline in different parts of the brain in adulthood and senium. Magn. Reson. Imaging. 11:1993;799-806.
32. Barker P.B., Soher B.J., Blackband S.J., Chatham J.C., Matthews V.P., Bryan R.N. Quantitation of proton NMR spectra of the human brain using tissue water as an internal concentration reference. NMR Biomed. 6:1993;89-94.
33. Narayana P.A., Fotedar L.K., Jackson E.F., Bohan T.P., Butler I.J., Wolinsky J.S. Regional in vivo proton magnetic resonance spectroscopy of brain. J. Magn. Reson. 83:1989;44-52.
34. Narayana P.A., Johnston D., Flamig D.P. In vivo proton magnetic resonance spectroscopy studies of human brain. Magn. Reson. Imaging. 9:1991;303-308.
35. Ernst T., Kreis R., Ross B.D. Absolute quantitation of water and metabolites in the human brain. I. Compartments and water. J. Magn. Reson. Series B. 102:1993;1-8.
36. Kreis R., Ernst T., Ross B.D. Absolute quantitation of water and metabolites in the human brain. II. Metabolite concentrations. J. Magn. Reson. Series B. 102:1993;9-19.
37. Hennig J., Pfister H., Ernst T., Ott D. Direct absolute quantification of metabolites in the human brain with in vivo localised proton spectroscopy. NMR Biomed. 5:1992;193-199.
38. Michaelis T., Merboldt K.D., Bruhn H., Hanicke W., Frahm J. Absolute concentrations of metabolites in the adult, human brain in vivo. Quantification of localised proton MR spectra. Radiology. 187:1993;219-227.
39. Danielsen E.R., Henriksen O. Absolute quantitative proton NMR spectroscopy based on the amplitude of the local water suppression pulse. Quantification of brain water and metabolites. NMR Biomed. 7:1994;311-318.
40. Soher B.J., Hurd R.E., Sailasuta N., Barker P.B. Quantitation of automated single-voxel proton MRS using cerebral water as an internal reference. Magn. Reson. Med. 36:1996;335-339.
41. Simmons, A.; Smail, M.; Moore, E.; Williams, S.C.R. Serial precision of metabolite peak area ratios and water referenced metabolite concentrations in proton MR spectroscopy of the human brain. Proceedings of the 5th Annual Meeting of the International Society for Magnetic Resonance in Medicine. Vancouver, Canada; 1997:483.
42. Webb P.G., Sailasutu N., Kohler S.J., Raidy T., Moats R.A., Hurd R.E. Automated single-voxel proton MRS Technical development and multi-site verification . Magn. Reson. Med. 31:1994;365-373.
43. Ordidge R.J., Bendall M.R., Gordon R.E., Connoly A. Volume selection for in vivo biological spectroscopy. Govil, Khetrapal, Savan. Magnetic Resonance in Biology and Medicine. 1985;387-397 McGraw Hill, New Delhi.
44. Frahm J., Bruhn H., Gyngell M.L., Merboldt K.D., Hanicke W., Sauter R. Localised high-resolution proton NMR spectroscopy using stimulated echoes. Initial applications to human brain in vivo. Magn. Reson. Med. 9:1989;79.
45. Conover W.W., Levy G. Topics in Carbon 13 Magnetic Resonance Spectroscopy. Vol. 4:1984;John Wiley and Sons, New York.
46. Signa User's Manual, General Electric, Milwaukee, WI, USA.
47. Marion D., Ikura M., Bax A. Improved solvent suppression in one and two-dimensional NMR spectra by convolution of time-domain data. J. Magn. Reson. 84:1989;425-430.
48. Simmons A., Arridge S.R., Barker G.J., Williams S.C.R. Simulation of MRI cluster plots and application to neurological segmentation. Magn. Reson. Imaging. 14:1996;73-92.
49. Charles H.C., Layzeras F., Tupler L.A., Krishnan K.R.R. Reproducibility of high spatial resolution proton magnetic resonance spectroscopic imaging in the human brain. Magn. Reson. Med. 35:1996;606-610.
50. Brief, E.; Whittall, K.P.; MacKay, A.L.; Li, D.K.B. Intra-subject reproducibility in quantitative 1H MRS. Proceedings of the 3rd Annual meeting of the Society for Magnetic Resonance, Nice, France; 1995:1970.
51. 1H MRS. Proceedings of the Second Meeting of the Society of Magnetic Resonance, San Fransisco, CA; 1994:45.